Question

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Resolved :No0.3%

11 comments11

Total Forecasters431

Community Prediction0.3% (0.1% - 1%)

Make a Prediction

50%

community: 0.3%

Did this actually happen?No

Community Baseline Score

96.7

Community Peer Score

13.0

Authors:

christian

Opened:

Jan 1, 2024

Closes:

Dec 31, 2024

Resolves:

Jan 1, 2025

ACX 2024 Prediction Contest

Health & Pandemics

Economy & Business

2024 Leaderboard

Food and Drug Administration

Ozempic and Blindness: What We Know About Weight Loss Side Effects

Newsweek•Feb 12, 2025

Some Ozempic users are developing serious eye issues that lead to blindness

New York Post•Feb 12, 2025

Weight loss drug Wegovy approved to treat heart disease in overweight and obese Australian patients

Guardian•Feb 18, 2025

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80.8%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%

Comments

? comments